Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-Ku, Chiba, 260-8677, Japan.
Department of Neurology, Juntendo University Hospital, Tokyo, Japan.
BMC Neurol. 2024 May 13;24(1):160. doi: 10.1186/s12883-024-03666-4.
Multiple system atrophy (MSA) is a progressive, incurable, life-threatening neurodegenerative disease uniquely characterized by the risk of sudden death, which makes diagnosis delivery challenging for neurologists. Empirical studies on breaking a diagnosis of MSA are scarce, with no guidelines currently established. This study aimed to investigate neurologists' current practices and experiences in delivering the diagnosis of MSA.
We conducted a multicenter online survey and employed a mixed-methods (quantitative and qualitative) study design in which responses to open-ended questions were analyzed qualitatively using critical incident technique.
Among the 194 neurologists surveyed, 166 opened the survey (response rate = 85.6%), of whom 144 respondents across various Japanese regions completed the survey. Accordingly, 92.3% and 82.8% of the participating neurologists perceived delivering the diagnosis of MSA and explaining the risk of sudden death as difficult, respectively. Factors independently associated with difficulties in diagnosis delivery included explaining the importance of the family decision making process in life-prolonging treatment, perceived difficulties in delivering information regarding the risk of sudden death, and perceived difficulties in differential diagnosis of MSA.
Our findings showed that the majority of neurologists perceived delivering the diagnosis of MSA and explaining the risk of sudden death as difficult, which could have been associated with the difficulty of breaking the diagnosis of MSA. Difficulty in conveying bad news in MSA are caused by various factors, such as empathic burden on neurologists caused by the progressive and incurable nature of MSA, the need to explain complex and important details, including the importance of the family decision-making process in life-prolonging treatment, difficulty of MSA diagnosis, and communication barriers posed by mental status and cognitive impairment in patients or their family members. Neurologists consider various factors in explaining the risk of sudden death (e.g., patient's personality, mental state, and degree of acceptance and understanding) and adjust their manner of communication, such as limiting their communication on such matters or avoiding the use of the term "sudden death" in the early stages of the disease. Although neurologists endeavor to meet the basic standards of good practice, there is room for the multiple aspects for improvement.
多系统萎缩(MSA)是一种进行性、无法治愈、危及生命的神经退行性疾病,其特征是突然死亡的风险,这使得神经病学家在诊断时面临挑战。关于打破 MSA 诊断的经验研究很少,目前也没有确立任何指南。本研究旨在调查神经病学家在诊断 MSA 时的当前做法和经验。
我们进行了一项多中心在线调查,并采用了混合方法(定量和定性)研究设计,对开放式问题的回答采用关键事件技术进行定性分析。
在接受调查的 194 名神经病学家中,有 166 名打开了调查(应答率为 85.6%),来自日本各地的 144 名应答者完成了调查。因此,92.3%和 82.8%的参与神经病学家分别认为诊断 MSA 和解释突然死亡的风险具有难度。与诊断传递困难相关的独立因素包括解释家庭决策过程在延长生命治疗中的重要性、认为传递突然死亡风险的信息具有难度、以及认为 MSA 的鉴别诊断具有难度。
我们的研究结果表明,大多数神经病学家认为诊断 MSA 和解释突然死亡的风险具有难度,这可能与 MSA 诊断的难度有关。在 MSA 中传递坏消息的困难是由多种因素引起的,例如 MSA 的进行性和不可治愈性给神经病学家带来的同理心负担、需要解释复杂而重要的细节,包括在延长生命治疗中家庭决策过程的重要性、MSA 诊断的难度以及患者或其家属的精神状态和认知障碍造成的沟通障碍。神经病学家在解释突然死亡风险时考虑了各种因素(例如患者的个性、精神状态以及接受和理解程度),并调整了他们的沟通方式,例如限制在这些问题上的沟通或在疾病早期避免使用“突然死亡”一词。尽管神经病学家努力达到良好实践的基本标准,但仍有多个方面需要改进。